ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS
· Real-Time Price · USD
3.92
0.72 (22.50%)
At close: Aug 14, 2025, 3:59 PM
ReShape Lifesciences Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | 0.00 | -8.16 | -11.37 | -19.66 | -10.87 | -21.56 | -2.06 | -8.6 | -10.31 | -1.19 | -3.47 | -7.37 | -16.64 | -5.16 | -17.38 | -36.47 | -42.61 |
PEG Ratio | -0.00 | 0.17 | 0.75 | 0.61 | -0.37 | 0.23 | 0.37 | 0.28 | 0.11 | -0.04 | -0.33 | -0.71 | 0.21 | -0.06 | -0.83 | 1.18 | 0.99 |
PS Ratio | 0.03 | 31.85 | 31.36 | 63.85 | 49.05 | 73.87 | 13.54 | 53.34 | 47.99 | 25.38 | 60.53 | 96.29 | 224.15 | 233.07 | 331.81 | 161.30 | 257.92 |
PB Ratio | 0.02 | -227.22 | 48.34 | 41.34 | 21.03 | 21.97 | 9.46 | 17.84 | 14.15 | 21.56 | 8.09 | 8.60 | 14.16 | 15.89 | 15.53 | 9.79 | 65.37 |
P/FCF Ratio | -0.01 | -83.68 | -231.11 | -92.45 | -46.02 | -59.59 | -10.49 | -17.95 | -21.66 | -27.14 | -31.92 | -43.28 | -74.06 | -209.65 | -155.96 | -251.32 | -399.4 |
P/OCF Ratio | -0.01 | -83.68 | -231.11 | -92.45 | -46.02 | -59.59 | -10.49 | -18.05 | -21.69 | -27.89 | -32.12 | -43.36 | -74.13 | -213.75 | -157.74 | -260.17 | -423.64 |
OCF/S Ratio | -1.9 | -0.38 | -0.14 | -0.69 | -1.07 | -1.24 | -1.29 | -2.96 | -2.21 | -0.91 | -1.88 | -2.22 | -3.02 | -1.09 | -2.1 | -0.62 | -0.61 |
Debt / Equity Ratio | 0.11 | -3.82 | 0.13 | 0.07 | 0.05 | 0.04 | 0.09 | 0.05 | 0.01 | 0.05 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | 0.06 | 0.03 |
Quick Ratio | 0.91 | 0.43 | 0.60 | 0.89 | 1.26 | 1.74 | 0.94 | 1.65 | 1.54 | 0.84 | 1.25 | 1.66 | 2.41 | 3.72 | 3.33 | 1.04 | 0.28 |
Current Ratio | 1.53 | 0.92 | 1.33 | 1.90 | 2.24 | 2.73 | 1.66 | 2.39 | 2.00 | 1.32 | 1.81 | 2.12 | 2.90 | 4.13 | 3.64 | 1.08 | 0.38 |
Asset Turnover | 0.17 | 0.38 | 0.41 | 0.31 | 0.24 | 0.18 | 0.28 | 0.19 | 0.14 | 0.28 | 0.10 | 0.07 | 0.05 | 0.06 | 0.04 | 0.03 | 0.09 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.13K | -1.18 | n/a | n/a | n/a | -1.27K | -454.06 | -21.52 | -3.77 |
Return on Equity | 1.20 | 6.96 | -1.06 | -0.53 | -0.48 | -0.25 | -1.15 | -0.52 | -0.34 | -4.54 | -0.58 | -0.29 | -0.21 | -0.77 | -0.22 | -0.07 | -0.38 |
Return on Assets | 0.23 | -0.37 | -0.28 | -0.25 | -0.27 | -0.16 | -0.45 | -0.29 | -0.16 | -1.49 | -0.43 | -0.23 | -0.17 | -0.65 | -0.2 | -0.03 | -0.14 |
Return on Invested Capital | -0.89 | -0.88 | -1.04 | -0.63 | -0.46 | -0.27 | -0.87 | -0.52 | -0.63 | -1.24 | -0.56 | -0.28 | -0.21 | -0.75 | -0.18 | -0.06 | -0.15 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.61 | 0.73 | 0.63 | 0.58 | 0.60 | 0.93 | 0.60 | 0.53 | 0.54 | 0.51 | 0.75 | 0.65 | 0.50 | 0.57 | 0.58 | 0.61 | 0.71 |
Net Profit Margin | 1.32 | -0.98 | -0.69 | -0.81 | -1.13 | -0.86 | -1.64 | -1.55 | -1.16 | -5.34 | -4.36 | -3.27 | -3.37 | -11.29 | -4.77 | -1.11 | -1.51 |
Pretax Profit Margin | 1.33 | -0.97 | -0.69 | -0.8 | -1.12 | -0.84 | -1.64 | -1.55 | -1.16 | -5.3 | -4.48 | -3.26 | -3.43 | -11.33 | -4.78 | -1.1 | -1.51 |
Operating Profit Margin | -1.98 | -0.36 | -0.77 | -1.05 | -1.14 | -0.96 | -1.44 | -1.76 | -2.46 | -1.51 | -4.4 | -3.2 | -3.44 | -11.32 | -4.04 | -1.05 | -0.7 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -1.65 | -0.35 | -0.77 | -1.04 | -1.13 | -0.95 | -1.42 | -1.76 | -2.44 | -5.08 | -1.55 | -2.88 | -3.1 | -11.14 | -3.89 | -0.85 | -1.24 |